Literature DB >> 19416295

Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors.

S B Debast1, N Vaessen, A Choudry, E A J Wiegers-Ligtvoet, R J van den Berg, E J Kuijper.   

Abstract

In the period April-September 2005, an outbreak of Clostridium difficile infection (CDI) due to PCR ribotype 027 occurred among 50 patients in a 341-bed community hospital in Harderwijk, The Netherlands. A retrospective case-control study was performed to identify risk factors specific for CDI, using a group of patients with CDI (n = 45), a group of randomly selected control patients without diarrhoea (n = 90), and a group of patients with non-infectious diarrhoea (n = 109). Risk factors for CDI and for non-CDI diarrhoea were identified using multiple logistic regression analysis. Independent risk factors for CDI were: age above 65 years (OR 2.6; 95% CI 1.0-5.7), duration of hospitalization (OR 1.04 per additional day; 95% CI 1.0-1.1), and antibiotic use (OR 12.5; 95% CI 3.2-48.1). Of the antibiotics used, cephalosporins and fluoroquinolones were identified as the major risk factors for development of CDI. The risk of developing CDI was particularly high in people receiving a combination of a cephalosporin and a fluoroquinolone (OR 57.5; 95% CI 6.8-483.6). The main factors affecting the risk of non-CDI diarrhoea were proton-pump inhibitors, immunosuppressive drugs, underlying digestive system disease, previous surgery, and gastric tube feeding. The outbreak ended only after implementation of restricted use of cephalosporins and a complete ban on fluoroquinolones, in addition to general hygienic measures, cohorting of patients in a separate ward, education of staff, and intensified environmental cleaning. The results of this study support the importance of appropriate antimicrobial stewardship in the control of hospital outbreaks with C. difficile PCR ribotype 027.

Entities:  

Mesh:

Year:  2009        PMID: 19416295     DOI: 10.1111/j.1469-0691.2009.02713.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  19 in total

1.  Association between Clostridium difficile infection and antimicrobial usage in a large group of English hospitals.

Authors:  Joao B Pereira; Tracey M Farragher; Mary P Tully; Jonathan Jonathan Cooke
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

2.  Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.

Authors:  K de With; F Allerberger; S Amann; P Apfalter; H-R Brodt; T Eckmanns; M Fellhauer; H K Geiss; O Janata; R Krause; S Lemmen; E Meyer; H Mittermayer; U Porsche; E Presterl; S Reuter; B Sinha; R Strauß; A Wechsler-Fördös; C Wenisch; W V Kern
Journal:  Infection       Date:  2016-06       Impact factor: 3.553

Review 3.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 4.  Clostridium difficile infection: epidemiology, risk factors and management.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-30       Impact factor: 46.802

5.  Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.

Authors:  Tadayuki Oshima; Liping Wu; Min Li; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2017-07-25       Impact factor: 7.527

6.  Analysis of ultra low genome conservation in Clostridium difficile.

Authors:  Joy Scaria; Lalit Ponnala; Tavan Janvilisri; Weiwei Yan; Lukas A Mueller; Yung-Fu Chang
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

7.  Management and prevention of recurrent clostridium difficile infection in patients after total joint arthroplasty: a review.

Authors:  Benjamin E Stein; William B Greenough; Simon C Mears
Journal:  Geriatr Orthop Surg Rehabil       Date:  2012-12

8.  Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027.

Authors:  Jeffrey T Wieczorkiewicz; Bert K Lopansri; Adam Cheknis; James R Osmolski; David W Hecht; Dale N Gerding; Stuart Johnson
Journal:  Antimicrob Agents Chemother       Date:  2015-11-02       Impact factor: 5.191

9.  The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients.

Authors:  Eavan G Muldoon; Lauren Epstein; Tanya Logvinenko; Susan Murray; Shira I Doron; David R Snydman
Journal:  Anaerobe       Date:  2013-10-15       Impact factor: 3.331

10.  When is an outbreak an outbreak? Using literature and discharge data to define Clostridioides difficile incidence changes referred to as outbreaks.

Authors:  C C Cohen; G Azhar; L Muggy
Journal:  J Hosp Infect       Date:  2020-03-20       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.